文献速递其他结缔组织病

原发性干燥综合征中活检证实的轻纤维神经病:神经病理性疼痛特征、自身抗体发现及组织病理学特点

Biopsy-Proven Small-Fiber Neuropathy in Primary Sjögren's Syndrome: Neuropathic Pain Characteristics, Autoantibody Findings, and Histopathologic Features.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2019-01-01

该研究比较23例原发性干燥综合征(SS)合并轻纤维神经病(SFN)患者与98例无SFN患者,发现SFN组男性比例更高、抗Ro52/抗Ro60抗体及类风湿因子阳性率更低、多克隆丙种球蛋白病更少;约45%患者以神经病理性疼痛先于干燥症状出现,约45%使用阿片类镇痛药;皮肤活检区分轴索损伤与背根神经节(DRG)损伤模式。

要点

  • SS合并SFN患者男性比例更高(30% vs 9%,P<0.01),多种自身抗体阳性率更低。
  • 约45%的SFN患者神经病理性疼痛先于干燥症状出现,约45%使用阿片类镇痛药。
  • 皮肤活检可区分轴索损伤(16例)与DRG损伤(7例),后者可能致不可逆神经元死亡。

核心结论

  • SS相关SFN在男性中更常见,多种自身抗体阳性率更低,常使用阿片类镇痛药,且可表现为非袜套-手套样疼痛。
  • 区分DRG损伤与轴索损伤具有重要意义,因靶向DRG的机制可能导致不可逆神经元细胞死亡。

研究设计与样本

  • 连续纳入23例合并纯型或混合型SFN的原发性SS患者,与98例无SFN的SS患者进行比较。
  • 通过皮肤活检测定表皮内神经纤维密度(IENFD),以近端大腿较远端小腿降低判定DRG变性,以远端小腿较近端大腿降低判定轴索变性。

主要发现

  • 13例纯型SFN与10例混合型SFN在疼痛强度、疼痛性质及治疗特征上无差异。
  • 10例(约45%)SFN患者神经病理性疼痛先于干燥症状出现,约45%使用阿片类镇痛药。
  • 与98例无SFN患者相比,23例SFN患者男性频率增高(30% vs 9%,P<0.01),抗Ro52(P=0.01)、抗Ro60抗体(P=0.01)、类风湿因子阳性(P<0.01)及多克隆丙种球蛋白病(P<0.01)频率降低。

临床怎么用

  • 对原发性SS患者出现神经病理性疼痛时,即使缺乏干燥症状,也应考虑SFN并进行皮肤活检评估。
  • 皮肤活检区分轴索损伤与DRG损伤模式,有助于判断预后及探索靶向DRG的治疗策略。

局限性

  • 样本量较小(SFN组23例),为单中心连续病例比较,结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Painful small-fiber neuropathies (SFNs) in primary Sjögren's syndrome (SS) may present as pure or mixed with concurrent large-fiber involvement. SFN can be diagnosed by punch skin biopsy results that identify decreased intra-epidermal nerve-fiber density (IENFD) of unmyelinated nerves. METHODS: We compared 23 consecutively evaluated patients with SS with pure and mixed SFN versus 98 patients without SFN. We distinguished between markers of dorsal root ganglia (DRG) degeneration (decreased IENFD in the proximal thigh versus the distal leg) versus axonal degeneration (decreased IENFD in the distal leg versus the proximal thigh). RESULTS: There were no differences in pain intensity, pain quality, and treatment characteristics in the comparison of 13 patients with pure SFN versus 10 patients with mixed SFN. Ten patients with SFN (approximately 45%) had neuropathic pain preceding sicca symptoms. Opioid analgesics were prescribed to approximately 45% of patients with SFN. When compared to 98 patients without SFN, the 23 patients with SFN had an increased frequency of male sex (30% versus 9%; P < 0.01), a decreased frequency of anti-Ro 52 (P = 0.01) and anti-Ro 60 antibodies (P = 0.01), rheumatoid factor positivity (P < 0.01), and polyclonal gammopathy (P < 0.01). Eleven patients had stocking-and-glove pain, and 12 patients had nonstocking-and-glove pain. Skin biopsy results disclosed patterns of axonal (16 patients) and DRG injury (7 patients). CONCLUSION: SS SFN had an increased frequency among male patients, a decreased frequency of multiple antibodies, frequent treatment with opioid analgesics, and the presence of nonstocking-and-glove pain. Distinguishing between DRG versus axonal injury is significant, especially given that mechanisms targeting the DRG may result in irreversible neuronal cell death. Altogether, these findings highlight clinical, autoantibody, and pathologic features that can help to define mechanisms and treatment strategies.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Birnbaum J, Lalji A, Saed A, et al. Biopsy-Proven Small-Fiber Neuropathy in Primary Sjögren's Syndrome: Neuropathic Pain Characteristics, Autoantibody Findings, and Histopathologic Features. Arthritis Care Res (Hoboken). 2019. PMID: 30221483. doi:10.1002/acr.23762

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。